Screener
Immix Biopharma, Inc. IMMX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | - | |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 53,084,455 shares issued and 53,012,092 shares outstanding at March 31, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 2025 | 5,307 | 5,301 |
| Additional paid-in capital | 198,903,047 | 198,293,956 |
| Accumulated other comprehensive income | 105,636 | 60,160 |
| Accumulated deficit | (114,549,971) | (104,463,284) |
| Treasury stock at cost, 72,363 shares as of March 31, 2026 and December 31, 2025 | (99,963) | (99,963) |
| Total stockholders’ equity | 84,364,056 | 93,796,170 |
| Total liabilities and stockholders’ equity | $95,816,057 | $104,840,341 |
Document
FAQ
- What is Immix Biopharma, Inc.'s total liabilities & equity?
- Immix Biopharma, Inc. (IMMX) reported total liabilities & equity of $95.82M in Q1 2026.
- How has Immix Biopharma, Inc.'s total liabilities & equity changed year-over-year?
- Immix Biopharma, Inc.'s total liabilities & equity increased by 381.7% year-over-year, from $19.89M to $95.82M.
- What is the long-term trend for Immix Biopharma, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s total liabilities & equity has grown at a 186.9% compound annual growth rate (CAGR), from $539.6K to $104.84M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Immix Biopharma, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude